Amyris CEO Kathy Fortmann was recently interviewed by Elaine Watson of AgFunder News, a leading publication covering agrifoodtech and the future of food and agriculture. Read the article here. In the in-depth discussion, Fortmann discusses how she has transformed Amyris, a vertically integrated biomanufacturing and biotechnology company specializing in precision fermentation, since taking the helm in 2024, with renewed operational discipline and a sharpened B2B business model.

Fortmann details how Amyris has refocused on recurring revenue, expanded into new markets, and evolved its approach to partnerships across the full biomanufacturing value chain, from strain engineering and R&D collaborations to licensing and commercial-scale manufacturing. She also discusses new Amyris innovations entering the market.

AgFunder News highlights how Amyris' precision fermentation facility in Barra Bonita, Brazil anchors a platform uniquely capable of taking specialty molecules from strain engineering through commercial-scale manufacturing. The article also explores why Fortmann believes biomanufacturing is at a genuine inflection point—driven by supply chain disruption, geopolitical instability, and growing demand for consistent, high-performance, sustainably produced ingredients.

Amyris is the only biotech company that goes across the whole spectrum from strain engineering to process development to scale-up and has successfully scaled a number of molecules and ingredients. – Kathy Fortmann, CEO

‍